Iranian Journal of Pediatrics

Published by: Kowsar

Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial

Mirhadi Mussavi 1 , Keyvan Mirnia 1 and Khairollah Asadollahi 2 , *
Authors Information
1 Department of Pediatrics, Faculty of Medicine, Pediatric Health Researches Center, University of Medical Sciences, Tabriz, IR Iran
2 Department of Social Medicine, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, IR Iran
Article information
  • Iranian Journal of Pediatrics: October 2016, 26 (5); e5743
  • Published Online: July 25, 2016
  • Article Type: Research Article
  • Received: February 19, 2016
  • Revised: May 15, 2016
  • Accepted: June 15, 2016
  • DOI: 10.5812/ijp.5743

To Cite: Mussavi M, Mirnia K, Asadollahi K. Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial, Iran J Pediatr. 2016 ; 26(5):e5743. doi: 10.5812/ijp.5743.

Copyright © 2016, Growth & Development Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Singh N, Hawley KL, Viswanathan K. Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis. Pediatrics. 2011; 128(6): 1588-95[DOI][PubMed]
  • 2. Soll R, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2001; 2: 144
  • 3. Soll R, Ozek E. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2009; (1): 141[DOI][PubMed]
  • 4. Ramanathan R. Animal-derived surfactants: where are we? The evidence from randomized, controlled clinical trials. J Perinatol. 2009; 29 Suppl 2: 38-43[DOI][PubMed]
  • 5. Rudiger M, Tolle A, Meier W, Rustow B. Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity. Am J Physiol Lung Cell Mol Physiol. 2005; 288(2): 379-83[DOI][PubMed]
  • 6. Ma CC, Ma S. The role of surfactant in respiratory distress syndrome. Open Respir Med J. 2012; 6: 44-53[DOI][PubMed]
  • 7. Halliday HL. Surfactants: past, present and future. J Perinatol. 2008; 28 Suppl 1: 47-56[DOI][PubMed]
  • 8. Engle WA, American Academy of Pediatrics Committee on F. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics. 2008; 121(2): 419-32[DOI][PubMed]
  • 9. Verder H, Agertoft L, Albertsen P, Christensen NC, Curstedt T, Ebbesen F, et al. [Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study]. Ugeskr Laeger. 1992; 154(31): 2136-9[PubMed]
  • 10. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants--2013 update. Neonatology. 2013; 103(4): 353-68[DOI][PubMed]
  • 11. Manizheh MG, Sanaz Y. Comparing the effect of two natural surfactant, Curosurf and Alveofact in treatment of respiratory distress syndrome in preterm infants. Int J Women’s Health Repr Sci. 2014; 2: 245-8
  • 12. Rojas MA, Lozano JM, Rojas MX, Laughon M, Bose CL, Rondon MA, et al. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics. 2009; 123(1): 137-42[DOI][PubMed]
  • 13. Corff KE, Greubel S, McCann DG, Williams R, Varner DL. Practical Considerations in the Selection and Use of Pulmonary Surfactant Therapy for Neonatal Respiratory Distress Syndrome in the Intensive Care Setting. J Pediatr Pharmacol Ther. 2006; 11: 161-8
  • 14. Baroutis G, Kaleyias J, Liarou T, Papathoma E, Hatzistamatiou Z, Costalos C. Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr. 2003; 162(7-8): 476-80[DOI][PubMed]
  • 15. Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K, North American Study G. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol. 2004; 21(3): 109-19[DOI][PubMed]
  • 16. Proquitte H, Dushe T, Hammer H, Rudiger M, Schmalisch G, Wauer RR. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants. Respir Med. 2007; 101(1): 169-76[DOI][PubMed]
  • 17. Malloy CA, Nicoski P, Muraskas JK. A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome. Acta Paediatr. 2005; 94(6): 779-84[DOI][PubMed]
  • 18. Yalaz M, Arslanoglu S, Akisu M, Atik T, Ergun O, Kultursay N. A comparison of efficacy between two natural exogenous surfactant preparations in premature infants with respiratory distress syndrome. Klin Padiatr. 2004; 216(4): 230-5[DOI][PubMed]
  • 19. Hammoud M, Al-Kazmi N, Alshemmiri M, Thalib L, Ranjani VT, Devarajan LV, et al. Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome. J Matern Fetal Neonatal Med. 2004; 15(3): 167-75[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments